Sylvie M Guichard (Sylvie Guichard)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Vascular Endothelial Growth Factor

Anti Inflammatory

Top Venues

Science translational medicine

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Maureen Caligiuri, Grace L Williams, Jennifer Castro, Linda Battalagine, Erik Wilker, Lili Yao, Shawn Schiller, Angela Toms, Ping Li, Eneida Pardo, Bradford Graves, Joey Azofeifa, Agustin Chicas, Torsten Herbertz, Maria Lai, Joel Basken, Kenneth W Wood, Qunli Xu, Sylvie M Guichard
FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer. Targeted oncology (2023)
Archana Shrestha, Mengna Chi, Kimberly Wagner, Astha Malik, Jennifer Korpik, Adam Drake, Keertik Fulzele, Sylvie M Guichard, Punam Malik
FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice. Blood advances 5 (9) (2021)
Erica Banks, Michael Grondine, Deepa Bhavsar, Evan Barry, Jason G Kettle, Venkatesh Pilla Reddy, Crystal Brown, Haiyun Wang, Jerome T Mettetal, Teresa Collins, Oladipupo Adeyemi, Ross Overman, Deborah Lawson, Alexander R Harmer, Corinne Reimer, Lisa Drew, Martin J Packer, Sabina Cosulich, Rhys D O Jones, Wenlin Shao, David Wilson, Sylvie M Guichard, Stephen E Fawell, Rana Anjum
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors. Science translational medicine 12 (541) (2021)